US bets on untested company to deliver COVID-19 vaccine

  • 📰 AP
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 51%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

ApiJect, a young injections company focused on the developing world, never wanted to work in America. Now they've got the biggest U.S. government contract to help deliver a COVID-19 vaccine. Read more from AP, frontlinepbs and GlobalRepCentre

FILE - In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. When precious vats of COVID-19 vaccine are finally ready, the ability to jab the lifesaving solution into the arms of Americans will require hundreds of millions of injections.

Trump administration officials would not say why they are investing so heavily in ApiJect’s technology. The company has made only about 1,000 prototypes to date, and it’s not clear whether those devices can deliver the vaccines that are currently in development. So far, the leading candidates are using traditional vials to hold the vaccine, and needles and syringes in their clinical trials.ApiJect founder Marc Koska never intended to vaccinate the United States.

According to Walker, the CEO, ApiJect wasn’t interested in a federal contract — they were aiming to change the developing world with quick, inexpensive injection devices that could save millions of lives. Walker continued to resist, he said, but Giroir — who is also a doctor specializing in pediatric critical care — “wasn’t big on taking no for an answer,” Walker said.

When the pandemic emerged weeks later, officials sounded the alarm about a potential shortage of needles and syringes to deliver a vaccine if and when one became available.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

frontlinepbs GlobalRepCentre I can’t wait to hear the podcast about how this debacle unfolded.

frontlinepbs GlobalRepCentre Who owns it?

frontlinepbs GlobalRepCentre What could go wrong?

frontlinepbs GlobalRepCentre Some ones friend? Campaign contributor?

frontlinepbs GlobalRepCentre hydroxychloroquine is proven effective and a lot cheaper.

frontlinepbs GlobalRepCentre The virus is fake. There is no virus. Definitely not getting jabbed by anyone with a mystery “vaccine “ from a government contracted “medical” corporation. Hard pass and fuck you.

frontlinepbs GlobalRepCentre Does anyone know the stock symbol for ApiJect?

frontlinepbs GlobalRepCentre Now let's see if a decent investigative journalist can dig around to see if any politicians will benefit from this contract.

frontlinepbs GlobalRepCentre foodworldorder

frontlinepbs GlobalRepCentre Grobble grobble orange man bad. Am I doing this correctly?

frontlinepbs GlobalRepCentre “The fact of this matter is, it would be crazy for people to just rely on us. I would be the first to say it,” said ApiJect CEO Jay Walker. “

frontlinepbs GlobalRepCentre I’m sure we will soon find out a bunch of GOP have stakes in the company

frontlinepbs GlobalRepCentre The incompetence of the kleptocracy is, apparently, the point. And of course it starts at the top of our government...

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 728. in RU

Россия Последние новости, Россия Последние новости